Literature DB >> 18571801

Cyclic resolution of racemic ibuprofen via coupled efficient lipase and acid-base catalysis.

Ying Liu1, Fang Wang, Tianwei Tan.   

Abstract

Extracellular lipase LIP prepared in our lab from the yeast Yarrowia lipolytica was used for the resolution of racemic ibuprofen. The (S)-enantiomer was preferred by lipase LIP, and the unreacted (R)-enantiomer was extracted and racemized in basic solvent-water medium to be re-resolved. Solvent, content of solvent, base concentration, and temperature have a strong effect on racemization. The (S)-ester was separated and hydrolyzed to (S)-ibuprofen in acidic dimethyl sulfoxide-water mixture containing 70% dimethyl sulfoxide. The high purity (S)-ibuprofen (ee = 0.98) was obtained using lipase LIP to catalyze hydrolysis of (S)-ester in 0.1 M phosphate buffer (pH = 8). (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18571801     DOI: 10.1002/chir.20578

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  3 in total

1.  Computation of interactive effects and optimization of process parameters for alkaline lipase production by mutant strain of Pseudomonas aeruginosa using response surface methodology.

Authors:  Deepali Bisht; Santosh Kumar Yadav; Nandan Singh Darmwal
Journal:  Braz J Microbiol       Date:  2013-04-09       Impact factor: 2.476

2.  Hydrolysis of ibuprofen nitrile and ibuprofen amide and deracemisation of ibuprofen using Nocardia corallina B-276.

Authors:  Ricardo Lievano; Herminia Inés Pérez; Norberto Manjarrez; Aida Solís; Myrna Solís-Oba
Journal:  Molecules       Date:  2012-03-12       Impact factor: 4.411

3.  Novel Ergot Alkaloids Production from Penicillium citrinum Employing Response Surface Methodology Technique.

Authors:  Memuna Ghafoor Shahid; Muhammad Nadeem; Ahmed Gulzar; Muhammad Saleem; Hafeez Ur Rehman; Gul Zareen Ghafoor; Muhammad Umar Hayyat; Laila Shahzad; Rabia Arif; Rubina Nelofer
Journal:  Toxins (Basel)       Date:  2020-06-29       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.